Background. Mesangial hypercellularity is a critical early histopathologica
l finding seen in human and experimental glomerular diseases. Hyperlipidemi
a and the glomerular deposition of atherogenic lipoproteins [for example, l
ow-density lipoprotein (LDL) and its oxidized variants, minimally oxidized/
modified LDL (mm-LDL)] are commonly associated with mesangial hypercellula
rity and the development of glomerular disease. This article reviews signal
transduction pathways involved in cell proliferation and provides evidence
for the participation of atherogenic lipoproteins in intracellular signali
ng pathways for mesangial cell proliferation. The mitogenic intracellular s
ignaling pathways are regulated by the activation of a series of transmembr
ane and cytoplasmic protein tyrosine kinases that converge into the activat
ion of Ras and downstream mitogen-activated protein (MAP) kinase. Activated
MAP kinase, through translocating into the nucleus and the activation of v
arious transcription factors and proto-oncogenes, regulates cellular prolif
eration.
Methods. Murine mesangial cells were stimulated with LDL and mm-LDL and wer
e analyzed for the tyrosine kinase activity, phosphorylation of membrane pr
oteins, activation of Ras and MAP kinase, and cell proliferation.
Results. The results indicated that the stimulation of mesangial cells with
LDL and, with greater activity, mm-LDL induced the phosphorylation of memb
rane platelet-derived growth factor (PDGF) and epidermal growth factor (EGF
) receptors, activated Ras, and resulted in sustained (up to 24 hr) activat
ion of MAP kinase. LDL/mm-LDL-mediated mesangial cell proliferation and MAP
kinase activation were dependent on the activation of tyrosine kinases.
Conclusions. We suggest that the accumulation of LDL and more potently its
oxidized forms within the glomerulus, through the activation of membrane re
ceptor tyrosine kinases, activate the Pas and MAP kinase signaling cascade
leading to DNA synthesis and subsequent cell proliferation.